Browse 315 brain cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.
Filter
1
Filter results
Results: 315
Study of Letrozole in Recurrent Gliomas
for
Brain Tumor
Location: Cincinnati OH
Sponsor: University of Cincinnati
Sex: All
Age: 18+
Code: NCT03122197
Early_phase1, Recruiting
The Effects of Intraoperative Tranexamic Acid on Perioperative Bleeding In Craniotomies
for
Brain Tumor, Bleeding
Location: Halifax
Sponsor: Stephen Lownie
Sex: All
Age: 18 - 70+
Code: NCT06229483
Phase3, Recruiting
Mapping of Human Cognition
for
Epilepsy, Brain Tumor
Location: Houston TX
Sponsor: The University of Texas Health Science Center, Houston
Sex: All
Age: 18 - 70+
Code: NCT05989893
Recruiting
A Phase II Study of Tucatinib and Ado-trastuzumab Emtansine (T-DM1) in Patients With HER2-positive Metastatic Solid Tumors and Metastases to Brain (TUCATEMEB)
for
Metastatic Solid Tumor, Brain Metastases
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT05673928
Phase2, Recruiting
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
for
Primary Brain Neoplasm
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 19+
Code: NCT03830151
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Comprehensive Clinical fMRI Software Solution to Enable Mapping of Critical Functional Networks and Cerebrovascular Reactivity in the Brain
for
Brain Tumor
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT05342454
Recruiting
Cognitive Training in the Virtual Reality Setting With Children Undergoing Radiotherapy for Brain Tumors
for
Brain Tumor
Location: Memphis TN
Sponsor: St. Jude Children's Research Hospital
Sex: All
Age: 8 - 22
Code: NCT05947045
Recruiting
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
for
Neoplasms, Brain, Glioblastoma Multiforme,
Location: Birmingham AL, St Louis MO, Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 3 - 22
Code: NCT03911388
Phase1, Recruiting
Post-Operative Dosing of Dexamethasone in Patients With Brain Tumors After a Craniotomy, PODS Trial
for
Low Grade Glioma, Malignant Brain Glioma,
Location: Atlanta GA
Sponsor: Emory University
Sex: All
Age: 18+
Code: NCT06132685
Phase2, Recruiting
Longitudinal Prospective Study of Neurocognition & Neuroimaging in Primary BT Patients
EXCLAIM: Exploring Combined Local and Systemic Approaches In Brain Metastasis: a Multi-cohort Randomized Phase II Study Evaluating Initial Response to Systemic Therapy and Subsequent Integration of Stereotactic Radiosurgery in Patients With Low-risk Brain Metastases and Central Nervous System-active
for
Brain Metastases
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT06649058
Phase2, Recruiting
Cognitive Biomarkers in Pediatric Brain Tumor Patients
for
Childhood Brain Tumor
Location: St Louis MO
Sponsor: Washington University School of Medicine
Sex: All
Age: 4 - 18
Code: NCT02914067
Recruiting
NTS-WBRT in Brain Metastases
for
Brain Metastases
Location: Boston MA
Sponsor: Massachusetts General Hospital
Sex: All
Age: 18+
Code: NCT05013892
Phase2, Recruiting
Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or More Brain Metastases
for
Brain Metastases
Location: Halifax, Boston MA, Quebec, Egg Harbor NJ, Montreal,
Sponsor: Canadian Cancer Trials Group
Sex: All
Age: 18+
Code: NCT03550391
Phase3, Recruiting
SRS Compared With FSRS for Treatment of Intact Metastatic Brain Disease, FRACTIONATE Trial
for
Metastatic Malignant Neoplasm in the Brain,
Location: Jacksonville FL, La Crosse WI, Eau Claire WI,
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT05222620
Phase2, Recruiting
New
A Study of Stereotactic Radiosurgery (SRS) in People With Brain Cancer Having Tumor Resection Surgery
for
Brain Metastasases
Location: Commack NY, Rockville Centre NY, Harrison NY,
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All
Age: 18+
Code: NCT07802353
Recruiting
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer